CAS: 103782-08-7 - ALLOSAMIDIN
Fórmula:C25H42N4O14
InChI:InChI=1/C25H42N4O14/c1-8(33)26-14-17(36)16(35)11(6-31)39-23(14)42-22-12(7-32)40-24(15(19(22)38)27-9(2)34)41-21-10(5-30)20-13(18(21)37)28-25(43-20)29(3)4/h10-24,30-32,35-38H,5-7H2,1-4H3,(H,26,33)(H,27,34)/t10-,11+,12+,13+,14+,15+,16+,17-,18+,19-,20-,21+,22+,23-,24-/m0/s1
- Sinónimos:
- .beta.-D-Allopyranoside, (3aR,4R,5R,6S,6aS)-2-(dimethylamino)-3a,5,6,6a-tetrahydro-4-hydroxy-6-(hydroxymethyl)-4H-cyclopentoxazol-5-yl 2-(acetylamino)-4-O-2-(acetylamino)-2-deoxy-.beta.-D-allopyranosyl-2-deoxy-
- (3aR,4R,5R,6S,6aS)-2-(dimethylamino)-4-hydroxy-6-(hydroxymethyl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]oxazol-5-yl 2-(acetylamino)-4-O-[2-(acetylamino)-2-deoxy-beta-D-allopyranosyl]-2-deoxy-beta-D-allopyranoside
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Allosamidin REF: TM-T26595CAS: 103782-08-7 | - - - | A consultar | Mié 08 Ene 25 | |
Allosamidin-d6 REF: 4Z-A-275002CAS: 103782-08-7 | - - - | A consultar | Mar 14 Ene 25 | |
Allosamidin REF: 4Z-A-275001CAS: 103782-08-7 | - - - | A consultar | Mar 14 Ene 25 | |
Allosamidin REF: 3D-OA10112CAS: 103782-08-7 | Min. 95% | A consultar | Mar 21 Ene 25 | |
Allosamidin REF: TR-A547900CAS: 103782-08-7 | - - - | 66.167,00 € | Mar 18 Feb 25 |
Allosamidin
Ref: TM-T26595
100mg | A consultar | ||
500mg | A consultar |
Ref: 4Z-A-275002
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Ref: 4Z-A-275001
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Allosamidin
Ref: 3D-OA10112
Tamaño no definido | A consultar |
Allosamidin
Producto controladoRef: TR-A547900
25mg | 66.167,00 € |